To gain additional insights into the functional role of RAB32 in gliomas, we performed GSEA using the TCGA and CGGA databases to identify significantly activated pathways in patients with high RAB32 expression in GBM as compared to those with low RAB32 expression. The gene discussed is RAB32; the disease is central nervous system cancer.